Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis.

Spanbroek R, Grabner R, Lotzer K, Hildner M, Urbach A, Ruhling K, Moos MP, Kaiser B, Cohnert TU, Wahlers T, Zieske A, Plenz G, Robenek H, Salbach P, Kuhn H, Radmark O, Samuelsson B, Habenicht AJ.

Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1238-43. Epub 2003 Jan 27.

3.

A leukocyte type of 12-lipoxygenase is expressed in human vascular and mononuclear cells. Evidence for upregulation by angiotensin II.

Kim JA, Gu JL, Natarajan R, Berliner JA, Nadler JL.

Arterioscler Thromb Vasc Biol. 1995 Jul;15(7):942-8.

PMID:
7600127
4.

Impact of intravenous oxygen therapy on the expression of reticulocyte-type 15-lipoxygenase in human volunteers.

Chaitidis P, Kreutzer FJ, Gerth C, Janata P, Kühn H.

Prostaglandins Leukot Essent Fatty Acids. 2004 Nov;71(5):271-6.

PMID:
15380813
5.

Differential leukotriene receptor expression and calcium responses in endothelial cells and macrophages indicate 5-lipoxygenase-dependent circuits of inflammation and atherogenesis.

Lötzer K, Spanbroek R, Hildner M, Urbach A, Heller R, Bretschneider E, Galczenski H, Evans JF, Habenicht AJ.

Arterioscler Thromb Vasc Biol. 2003 Aug 1;23(8):e32-6. Epub 2003 Jun 19.

PMID:
12816882
6.

Simultaneous expression of leukocyte-type 12-lipoxygenase and reticulocyte-type 15-lipoxygenase in rabbits.

Berger M, Schwarz K, Thiele H, Reimann I, Huth A, Borngräber S, Kühn H, Thiele BJ.

J Mol Biol. 1998 May 22;278(5):935-48.

PMID:
9600854
7.

The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis.

Lötzer K, Funk CD, Habenicht AJ.

Biochim Biophys Acta. 2005 Sep 5;1736(1):30-7. Review.

PMID:
16081317
8.

Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3.

Navab M, Hama SY, Anantharamaiah GM, Hassan K, Hough GP, Watson AD, Reddy ST, Sevanian A, Fonarow GC, Fogelman AM.

J Lipid Res. 2000 Sep;41(9):1495-508.

9.

The potential role of antileukotriene drugs in atherosclerosis.

Spanbroek R, Habenicht AJ.

Drug News Perspect. 2003 Oct;16(8):485-9. Review.

PMID:
14668944
10.

Effects of silencing leukocyte-type 12/15-lipoxygenase using short interfering RNAs.

Li SL, Dwarakanath RS, Cai Q, Lanting L, Natarajan R.

J Lipid Res. 2005 Feb;46(2):220-9. Epub 2004 Dec 1.

11.

15-Lipoxygenase-2 is expressed in macrophages in human carotid plaques and regulated by hypoxia-inducible factor-1alpha.

Hultén LM, Olson FJ, Aberg H, Carlsson J, Karlström L, Borén J, Fagerberg B, Wiklund O.

Eur J Clin Invest. 2010 Jan;40(1):11-7. doi: 10.1111/j.1365-2362.2009.02223.x. Epub 2009 Nov 12.

PMID:
19912316
12.

The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm.

Zhao L, Moos MP, Gräbner R, Pédrono F, Fan J, Kaiser B, John N, Schmidt S, Spanbroek R, Lötzer K, Huang L, Cui J, Rader DJ, Evans JF, Habenicht AJ, Funk CD.

Nat Med. 2004 Sep;10(9):966-73. Epub 2004 Aug 22.

13.

Reticulocyte 15-lipoxygenase-I is important in acetylcholine-induced endothelium-dependent vasorelaxation in rabbit aorta.

Tang X, Holmes BB, Nithipatikom K, Hillard CJ, Kuhn H, Campbell WB.

Arterioscler Thromb Vasc Biol. 2006 Jan;26(1):78-84. Epub 2005 Oct 20.

PMID:
16239596
14.

Low density lipoprotein receptor-related protein is required for macrophage-mediated oxidation of low density lipoprotein by 12/15-lipoxygenase.

Xu W, Takahashi Y, Sakashita T, Iwasaki T, Hattori H, Yoshimoto T.

J Biol Chem. 2001 Sep 28;276(39):36454-9. Epub 2001 Jul 30.

15.

Essential roles of lipoxygenases in LDL oxidation and development of atherosclerosis.

Takahashi Y, Zhu H, Yoshimoto T.

Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):425-31. Review.

PMID:
15706089
16.

The rat leukocyte-type 12-lipoxygenase exhibits an intrinsic hepoxilin A3 synthase activity.

Nigam S, Patabhiraman S, Ciccoli R, Ishdorj G, Schwarz K, Petrucev B, Kühn H, Haeggström JZ.

J Biol Chem. 2004 Jul 9;279(28):29023-30. Epub 2004 May 3.

17.

5-lipoxygenase expression in dendritic cells generated from CD34(+) hematopoietic progenitors and in lymphoid organs.

Spanbroek R, Hildner M, Steinhilber D, Fusenig N, Yoneda K, Rådmark O, Samuelsson B, Habenicht AJ.

Blood. 2000 Dec 1;96(12):3857-65.

18.

S100A8 and S100A9 in human arterial wall. Implications for atherogenesis.

McCormick MM, Rahimi F, Bobryshev YV, Gaus K, Zreiqat H, Cai H, Lord RS, Geczy CL.

J Biol Chem. 2005 Dec 16;280(50):41521-9. Epub 2005 Oct 10.

19.

Arachidonate 15-lipoxygenase of reticulocyte-type in human rheumatoid arthritis type B synoviocytes and modulation of its activity by proinflammatory cytokines.

Liagre B, Vergne P, Rigaud M, Beneytout JL.

J Rheumatol. 1999 May;26(5):1044-51. Erratum in: J Rheumatol 1999 Jul;26(7):1645.

PMID:
10332966
20.

Localization of nonpancreatic secretory phospholipase A2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteins.

Hurt-Camejo E, Andersen S, Standal R, Rosengren B, Sartipy P, Stadberg E, Johansen B.

Arterioscler Thromb Vasc Biol. 1997 Feb;17(2):300-9.

PMID:
9081685

Supplemental Content

Support Center